Axonics, Inc.
DelistedCIK 1603756fmd_19ST3XQFCSYBW5ATQWYEN60C37Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2017 to Sep 30, 2024, 29 periods
Loading
Latest annual · FY2023
Millions- Total revenues
- 366
- Gross profit
- 275
- Operating income
- (26)
- Net income
- (6)
- Free cash flow
- (6)
Latest quarter · Q3 FY2024
Millions- Free cash flow
- (2)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2020 to FY2023
- +48.7%
- Revenue, 5 yearsFY2018 to FY2023
- +249.1%
- Net income, 5 yearsFY2018 to FY2023
- n/m
Axonics, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Revenue | $366.4 million | $273.7 million | +33.9% | 10-K 2024-02-29 · proof |
| Gross profit | $274.6 million | $197.7 million | +38.9% | 10-K 2024-02-29 · proof |
| Operating income | -$26.1 million | -$64.9 million | 10-K 2024-02-29 · proof | |
| Net income | -$6.1 million | -$59.7 million | 10-K 2024-02-29 · proof | |
| Cash from operating activities | -$2 million | $3.2 million | -163.2% | 10-K 2024-02-29 · proof |
| Free cash flow | -$5.6 million | $968,000 | -675% | 10-K 2024-02-29 · proof |
| Total assets | $719.9 million | $659.4 million | +9.2% | 10-K 2024-02-29 · proof |
| Total liabilities | $82.4 million | $89.2 million | -7.7% | 10-K 2024-02-29 · proof |
| Cash and cash equivalents | $104.8 million | $238.8 million | -56.1% | 10-K 2024-02-29 · proof |
- What was Axonics, Inc.'s revenue in fiscal 2023?
- Axonics, Inc. reported revenue of $366.4 million for fiscal 2023 (the year ended Dec 31, 2023), against $273.7 million the year before (+33.9%). Source: the 10-K filed with the SEC on Feb 29, 2024. SEC
- What was Axonics, Inc.'s gross profit in fiscal 2023?
- Axonics, Inc. reported gross profit of $274.6 million for fiscal 2023 (the year ended Dec 31, 2023), against $197.7 million the year before (+38.9%). Source: the 10-K filed with the SEC on Feb 29, 2024. SEC
- What was Axonics, Inc.'s operating income in fiscal 2023?
- Axonics, Inc. reported operating income of -$26.1 million for fiscal 2023 (the year ended Dec 31, 2023), against -$64.9 million the year before. Source: the 10-K filed with the SEC on Feb 29, 2024. SEC
- What was Axonics, Inc.'s net income in fiscal 2023?
- Axonics, Inc. reported net income of -$6.1 million for fiscal 2023 (the year ended Dec 31, 2023), against -$59.7 million the year before. Source: the 10-K filed with the SEC on Feb 29, 2024. SEC
- What was Axonics, Inc.'s cash from operating activities in fiscal 2023?
- Axonics, Inc. reported cash from operating activities of -$2 million for fiscal 2023 (the year ended Dec 31, 2023), against $3.2 million the year before (-163.2%). Source: the 10-K filed with the SEC on Feb 29, 2024. SEC
- What was Axonics, Inc.'s free cash flow in fiscal 2023?
- Axonics, Inc. reported free cash flow of -$5.6 million for fiscal 2023 (the year ended Dec 31, 2023), against $968,000 the year before (-675%). Source: the 10-K filed with the SEC on Feb 29, 2024. SEC
- What are Axonics, Inc.'s total assets?
- As of Dec 31, 2023, Axonics, Inc. reported total assets of $719.9 million, against $659.4 million a year earlier (+9.2%). Source: the 10-K filed with the SEC on Feb 29, 2024. SEC
- What are Axonics, Inc.'s total liabilities?
- As of Dec 31, 2023, Axonics, Inc. reported total liabilities of $82.4 million, against $89.2 million a year earlier (-7.7%). Source: the 10-K filed with the SEC on Feb 29, 2024. SEC
- What are Axonics, Inc.'s cash and cash equivalents?
- As of Dec 31, 2023, Axonics, Inc. reported cash and cash equivalents of $104.8 million, against $238.8 million a year earlier (-56.1%). Source: the 10-K filed with the SEC on Feb 29, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1603756&period_type=annual&limit=5"Information only, not investment advice.